Strata Critical Medical, Inc.

SRTANASDAQIndustrials● Active

$5.87

+$0.08(+1.38%)

Market Cap$507910966

P/E Ratio—

52W High$6.5

52W Low$3.51

Avg Volume926K

Open$5.90

Beta2.20

Overview

Strata Critical Medical, Inc.（SRTA）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

srta · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 6 位华尔街分析师

Buy

6 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 6 · 买入占比: 100.0%

12 个月目标价

High

$7.25

Consensus

$7.25

+24.0% upside

Low

$7.25

Median: $7.25 · Last Close: $5.84

Strata Critical Medical, Inc.（SRTA）的分析师共识为 Buy，基于过去 3 个月内 6 位华尔街分析师的评级。SRTA 的 12 个月平均目标价为 $7.25，相对当前价 $5.84 代表 +24.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

Bull

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$6.05	↑ 3.43%	$6.00	$6.09

1-day model range: $6–$6.09. Peak: $6.09 (+3.43%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$5	$5	$5	-15.9%
2028	$4	$4	$5	-23.3%
2029	$4	$4	$5	-27.0%
2030	$4	$4	$4	-28.9%
2031	$4	—	$4	-30.0%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

57%7%36%

8Buy

1Neutral

5Sell

RSI (14)59.4Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · SRTA · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$6.07SELL

MA 10$6.17SELL

MA 20$5.85SELL

MA 50$5.10BUY

MA 100$4.91BUY

MA 200$4.89BUY

Current $SRTA · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$6.00SELL

EMA 10$6.01SELL

EMA 20$5.83BUY

EMA 50$5.37BUY

EMA 100$5.08BUY

EMA 200$4.80BUY

Current $SRTA · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2025-09-17	Lake Street	Maintains	Buy→Buy
2024-10-29	JP Morgan	Maintains	Overweight→Overweight
2023-08-22	Citigroup	Maintains	Buy→Buy
2023-08-10	Credit Suisse	Maintains	Outperform→Outperform
2023-05-12	Oppenheimer	Maintains	Outperform→Outperform
2023-05-12	Credit Suisse	Maintains	Outperform→Outperform
2023-03-15	Credit Suisse	Maintains	Outperform→Outperform
2023-03-15	JP Morgan	Maintains	Overweight→Overweight
2023-03-15	Oppenheimer	Maintains	Outperform→Outperform
2023-01-26	JP Morgan	Maintains	Overweight→Overweight

Lake Street2025-09-17

Maintains

Buy→Buy

JP Morgan2024-10-29

Maintains

Overweight→Overweight

Citigroup2023-08-22

Maintains

Buy→Buy

Credit Suisse2023-08-10

Maintains

Outperform→Outperform

Oppenheimer2023-05-12

Maintains

Outperform→Outperform

Credit Suisse2023-05-12

Maintains

Outperform→Outperform

Credit Suisse2023-03-15

Maintains

Outperform→Outperform

JP Morgan2023-03-15

Maintains

Overweight→Overweight

Oppenheimer2023-03-15

Maintains

Outperform→Outperform

JP Morgan2023-01-26

Maintains

Overweight→Overweight

Wall Street analysts have recently issued updated ratings on Strata Critical Medical, Inc. (SRTA) stock. Of the recent 19 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover SRTA.

分析师推荐趋势

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

SRTA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$245M

↓ 10.7% YoY

Revenue Next Year

$214M

↓ 12.6% YoY

EPS This Year

$-0.34

EPS Next Year

$-0.01

↓ 97.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SRTA EPS of $-0.34 for the current fiscal year, based on estimates from 1 analysts. The SRTA revenue forecast is $245M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

SRTA 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SRTA 的共识目标价为 $7.25（+24.0% 上行空间），分析师共识为 Buy。

SRTA 的短期预测（明日）为 $6.05（+3.43%）。 SRTA 对 2027 年的股价预测均值为 $5。 SRTA 对 2030 年的预测区间为 $4–$4。

Strata Critical Medical, Inc. 在 NASDAQ 上市，代码 SRTA。SRTA 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

SRTA 预测 · 8 个问题

根据 6 位华尔街分析师，SRTA 的 12 个月平均目标价为 $7.25，最高 $7.25、最低 $7.25。若有图表，中位目标价可在上方查看。相对当前价 $5.84，隐含约 +24.0% 的上行空间。

SRTA 目标价SRTA 分析师目标价SRTA 12个月目标价目标价 SRTA

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.